87
Participants
Start Date
September 30, 2007
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
TS-1 and Eloxatin
"S-1 80 mg/m2/day on day 1-14 Oxaliplatin 130 mg/m2 IV for 2 hour on day 1 Every 3 week~Number of Cycles: until progression or unacceptable toxicity"
Seoul National University Hospital, Seoul
Collaborators (1)
Korean Cancer Study Group
OTHER
National Cancer Center, Korea
OTHER_GOV
Seoul National University Bundang Hospital
OTHER
Samsung Medical Center
OTHER
Asan Medical Center
OTHER
Severance Hospital
OTHER
Seoul National University Hospital
OTHER